Literature DB >> 21614636

Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone.

Melissa D Howard1, Andrei Ponta, Allison Eckman, Michael Jay, Younsoo Bae.   

Abstract

PURPOSE: To develop polymer micelles for the tunable release of Dexamethasone (DEX) in tumors.
METHODS: DEX was conjugated to poly(ethylene glycol)-poly(aspartate) block copolymers using hydrazone, ester, or hydrazone-ester dual linkers. Ketonic acids containing 3, 4, and 5 methylene groups were used as spacers to separate the dual linkers. Polymer micelles from the DEX-conjugated polymers were tested for drug release at different pH values and carboxylesterase activity levels.
RESULTS: DLS measurements and (1)H-NMR analysis confirmed all DEX-loaded micelles were <100 nm with core-shell structure. Single linker micelles appeared unsuitable to release DEX preferentially in acidic tumor tissues. Hydrazone linkages between DEX and polymers were non-degradable at both pH 7.4 and 5.0. Ester linkages stable at pH 5.0 were unstable at pH 7.4. Hydrazone-ester dual linkers suppressed DEX release at pH 7.4 while accelerating drug release at pH 5.0. DEX release decreased at pH 5.0 as the length of ketonic acid increased but was independent of spacer length at pH 7.4. Dual linker micelles were stable in the presence of carboxylesterases, suggesting DEX release was primarily due to pH-dependent hydrolysis.
CONCLUSION: Tunable release of DEX was achieved using pH-sensitive polymer micelles with hydrazone-ester dual linkers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21614636     DOI: 10.1007/s11095-011-0470-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  47 in total

Review 1.  Drug-polymer conjugates containing acid-cleavable bonds.

Authors:  F Kratz; U Beyer; M T Schütte
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1999       Impact factor: 4.889

Review 2.  Drug interactions in cancer therapy.

Authors:  Charity D Scripture; William D Figg
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 3.  Preclinical and clinical studies of anticancer agent-incorporating polymer micelles.

Authors:  Yasuhiro Matsumura; Kazunori Kataoka
Journal:  Cancer Sci       Date:  2009-04       Impact factor: 6.716

4.  Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases.

Authors:  Keiran S M Smalley; Nikolas K Haass; Patricia A Brafford; Mercedes Lioni; Keith T Flaherty; Meenhard Herlyn
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

5.  Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.

Authors:  Bin Li; Meghan Sedlacek; Indumathi Manoharan; Rathnam Boopathy; Ellen G Duysen; Patrick Masson; Oksana Lockridge
Journal:  Biochem Pharmacol       Date:  2005-10-06       Impact factor: 5.858

6.  Mixed pH-sensitive polymeric micelles for combination drug delivery.

Authors:  Younsoo Bae; Adam W G Alani; Nicole C Rockich; T S Z Chung Lai; Glen S Kwon
Journal:  Pharm Res       Date:  2010-08-11       Impact factor: 4.200

Review 7.  Polymeric micelles for drug delivery.

Authors:  S R Croy; G S Kwon
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

8.  Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.

Authors:  P E Kristjansen; Y Boucher; R K Jain
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

Review 9.  Reversible covalent chemistry in drug delivery.

Authors:  Kevin R West; Sijbren Otto
Journal:  Curr Drug Discov Technol       Date:  2005-09

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  10 in total

Review 1.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

2.  Comparison of Dialysis- and Solvatofluorochromism-Based Methods to Determine Drug Release Rates from Polymer Nanoassemblies.

Authors:  Derek Reichel; Younsoo Bae
Journal:  Pharm Res       Date:  2016-11-21       Impact factor: 4.200

3.  Polymeric conjugates for drug delivery.

Authors:  Nate Larson; Hamidreza Ghandehari
Journal:  Chem Mater       Date:  2012-01-04       Impact factor: 9.811

4.  Drug release patterns and cytotoxicity of PEG-poly(aspartate) block copolymer micelles in cancer cells.

Authors:  Allison M Eckman; Eleftheria Tsakalozou; Nayon Y Kang; Andrei Ponta; Younsoo Bae
Journal:  Pharm Res       Date:  2012-02-10       Impact factor: 4.200

Review 5.  Self-assembling prodrugs.

Authors:  Andrew G Cheetham; Rami W Chakroun; Wang Ma; Honggang Cui
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

6.  Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity.

Authors:  Daniel Scott; Jürgen Rohr; Younsoo Bae
Journal:  Int J Nanomedicine       Date:  2011-11-08

7.  Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy.

Authors:  Jieqiong Zhan; Zhiqiang Ma; Dan Wang; Xinfang Li; Xiangui Li; Lijing Le; Anfeng Kang; Pengwei Hu; Lan She; Feng Yang
Journal:  Int J Nanomedicine       Date:  2017-04-10

Review 8.  Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects.

Authors:  Natallia V Dubashynskaya; Anton N Bokatyi; Yury A Skorik
Journal:  Biomedicines       Date:  2021-03-27

9.  Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery.

Authors:  Eva Kicková; Stefano Salmaso; Francesca Mastrotto; Paolo Caliceti; Arto Urtti
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.321

10.  Pharmacokinetics of Pullulan-Dexamethasone Conjugates in Retinal Drug Delivery.

Authors:  Eva Kicková; Amir Sadeghi; Jooseppi Puranen; Shirin Tavakoli; Merve Sen; Veli-Pekka Ranta; Blanca Arango-Gonzalez; Sylvia Bolz; Marius Ueffing; Stefano Salmaso; Paolo Caliceti; Elisa Toropainen; Marika Ruponen; Arto Urtti
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.